These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 13602773)

  • 21. [Chemotherapeutic properties of methazid in experimental tuberculosis (generalized tuberculosis and tuberculous meningitis)].
    PERSHIN GN; MAKEEVA OO; IAKOVLEVA AI
    Probl Tuberk; 1958; 36(1):71-9. PubMed ID: 13554325
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of cyanacetic acid hydrazide in anti-tuberculosis therapy on indices of organic resistance; clinico-functional studies].
    SISTI MA; SCODITTI G
    Lotta Tuberc; 1957 Sep; 27(9):760-2 passim. PubMed ID: 13515423
    [No Abstract]   [Full Text] [Related]  

  • 23. Actions of isonicotinic acid hydrazide and compounds of related structure on DOPA decarboxylase.
    GONNARD P; NGUYEN CHI JP
    Bull Soc Chim Biol (Paris); 1958; 40(2-3):485-95. PubMed ID: 13546876
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cyanacetic acid hydrazide associated with dihydrostreptomycin in the treatment of pulmonary tuberculosis].
    SEREMBE M
    Minerva Med; 1957 Sep; 48(74):2931-5. PubMed ID: 13483308
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experimental tuberculosis produced by phthivazid-resistant mutants of the culture H 37 Rv].
    Zemskova ZS; Sergeev VV
    Probl Tuberk; 1967; 45(9):77-82. PubMed ID: 4974608
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of isoniazid para-aminosalicylate in treatment of urogenital tuberculosis].
    CIBERT J; BARBIER J
    Presse Med (1893); 1959 Apr; 67(21):841-2. PubMed ID: 13658007
    [No Abstract]   [Full Text] [Related]  

  • 27. [Intermittent method for the treatment of experimental tuberculosis with streptomycin only and streptomycin combined with methazid].
    Makeeva OO; Pershin GN
    Probl Tuberk; 1965; 43(5):71-8. PubMed ID: 5892890
    [No Abstract]   [Full Text] [Related]  

  • 28. Rational design of new antituberculosis agents: receptor-independent four-dimensional quantitative structure-activity relationship analysis of a set of isoniazid derivatives.
    Pasqualoto KF; Ferreira EI; Santos-Filho OA; Hopfinger AJ
    J Med Chem; 2004 Jul; 47(15):3755-64. PubMed ID: 15239654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Research on tuberculosis in mice. VII. Effect & resistance of isonicotinic acid hydrazide methanesulfonate].
    IWASHITA I
    Kekkaku; 1957 Sep; 32(9):489-94. PubMed ID: 13482103
    [No Abstract]   [Full Text] [Related]  

  • 30. On the role of isoniazid in the treatment of tuberculosis.
    BASU UP
    J Indian Med Assoc; 1956 Dec; 27(12):430-1. PubMed ID: 13398639
    [No Abstract]   [Full Text] [Related]  

  • 31. Simplification of isoniazid phenotyping procedure to promote its application in the chemotherapy of tuberculosis.
    Eidus L; Varughese P; Hodgkin MM; Hsu AH; McRae KB
    Bull World Health Organ; 1973; 49(5):507-16. PubMed ID: 4547302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of acetylator phenotype based on the ratio of acetylisoniazid to isoniazid in urine following an oral dose of ordinary isoniazid.
    Raghupati Sarma G; Kannapirin G; Narayana AS; Radhakrishna S; Tripathy SP
    Indian J Med Res; 1976 Jan; 64(1):1-8. PubMed ID: 1270091
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chemoprophylaxis and early chemotherapy of experimental primary tuberculous infections].
    Strakhova VM
    Probl Tuberk; 1965; 43(6):59-64. PubMed ID: 5892631
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effectiveness of antibacterial preparations incorporated into liposomes in the treatment of experimental tuberculosis].
    Kurunov IuN; Nikolin VP; Kaledin VI; Matienko NA; Budker VG
    Probl Tuberk; 1982 Oct; (10):54-8. PubMed ID: 7178105
    [No Abstract]   [Full Text] [Related]  

  • 35. [Saluzid content of biological fluids in meningeal tuberculosis patients; dosage of preparation; clinical and experimental research].
    BUSKINA VA
    Probl Tuberk; 1957; 35(4):95-100. PubMed ID: 13453403
    [No Abstract]   [Full Text] [Related]  

  • 36. [High-performance liquid chromatography for detecting the concentrations of isoniazid and acetylisoniazid in spinal tuberculosis].
    Liu P; Jiang JM; Zhou ZF
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Feb; 30(2):364-7. PubMed ID: 20159724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of isonicotinoylhydrazones from anacardic acid and their in vitro activity against Mycobacterium smegmatis.
    Swamy BN; Suma TK; Rao GV; Reddy GC
    Eur J Med Chem; 2007 Mar; 42(3):420-4. PubMed ID: 17112641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of pulmonary tuberculosis with high dosage of isoniazid derivative (Na-methansulfonate-IHMS) combined with PAS. The results of primary treatment of infiltrative caseous lesions].
    OHSATO T
    Kekkaku; 1960 Oct; 35():668-74. PubMed ID: 13730529
    [No Abstract]   [Full Text] [Related]  

  • 39. [Epidemiological importance of resistant strains of Mycobacterium tuberculosis (experimental study)].
    Chertkova EI; Udilova NN; Chernigovskaia NN
    Probl Tuberk; 1966; 44(7):67-71. PubMed ID: 4969292
    [No Abstract]   [Full Text] [Related]  

  • 40. [A case of isoniazid sodium methanesulfonate induced interstitial pneumonia].
    Matsushima H; Sugita Y; Yanagisawa T; Ubukata M; Kurosawa T; Yoshida F; Kanazawa M
    Kekkaku; 2003 May; 78(5):401-6. PubMed ID: 12806983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.